|
1
|
Hohenleutner U, Landthaler M, Hamm H and
Sebastian G: Hemangiomas of infancy and childhood. J Dtsch Dermatol
Ges. 5:334–338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Uihlein LC, Liang MG and Mulliken JB:
Pathogenesis of infantile hemangiomas. Pediatric Annals. 41:1–6.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chakkittakandiyil A, Phillips R, Frieden
IJ, Siegfried E, Lara-Corrales I, Lam J, Bergmann J, Bekhor P,
Poorsattar S and Pope E: Timolol maleate 0.5% or 0.1% gel-forming
solution for infantile hemangiomas: A retrospective, multicenter,
cohort study. Pediatr Dermatol. 29:28–31. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pope E and Chakkittakandiyil A: Topical
timolol gel for infantile hemangiomas: A pilot study. Arch
Dermatol. 146:564–565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou IQ: Radiation treatment of nuclear
applicationThe Operation Standard in Clinical Technology Nuclear
Medicine Fascicule. Chinese Medical Association. People's Military
Medical Press; Beijing: pp. 194–196. 2004
|
|
6
|
Wang YM, Geng F, Zha ZY, Cheng R, Zhang
ZY, Su WJ and Zhang YX: Effectiveness of 0.5% solution of topical
maleate for infantile Hemangiomas. Zu Zhi Gon Cheng Yu Zhong Jian
Wai Ke Za Zhi She. 8:208–212. 2012.(In Chinese).
|
|
7
|
Tang ZW, Huang JH and Tang JH: Clinical
efficacy of 90Sr-90Y applicator combined with
propranolol treatment on large infantile cutaneous hemangiomas.
Zhong Hua He Yi Xue Xa Zhi. 33:49–51. 2013.(In Chinese).
|
|
8
|
Lin TS and Chen WM: Clinical analysis of
90Sr-90Y applicator treatment for 2862
infantile cutaneous capillary hemangiomas. Fu Jian Yi Yao Za Zhi
She. 32:21–22. 2010.(In Chinese).
|
|
9
|
Xi Z, Chen F and Lu L: Effectiveness
analysis of 90Sr/90Y applicator treatment for
107 infantile capillary hemangiomas. Biao Ji Mian Yi Fen Xi Yu Lin
Chuang Bian Ji Bu. 19:247–248. 2012.(In Chinese).
|
|
10
|
Zhang JD, Wang YC, Lv C, et al: Analysis
of nuclide radiation treatment for 1076 infantile hemangiomas. Ren
Min Jun Yi. 54:224–225. 2011.(In Chinese).
|
|
11
|
Fragu P, Lemarchand-Venencie F, Benhamou
S, François P, Jeannel D, Benhamou E, Sezary-Lartigau I and Avril
MF: Long-term effect in skin and thyroid after radiotherapy for
skin angiomas: A French retrospective cohort study. Eur J Cancer.
27:1215–1222. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan ST, Itinteang T and Leadbitter P:
Low-dose propranolol for infantile haemangioma. J Plast Reconstr
Aesthet Surg. 64:292–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schiestl C, Neuhaus K, Zoller S, Subotic
U, Forster-Kuebler I, Michels R, Balmer C and Weibel L: Efficacy
and safety of propranolol as fist-line treatment for infantile
hemangiomas. Eur J Pediatr. 170:493–501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van Buskirk EM and Fraunfelder FT: Timolol
and glaucoma. Arch Ophthalmol. 99:6961981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ciudad Blanco C, Campos Domínguez M,
Moreno García B, Villanueva Álvarez-Santullano CA, Berenguer
Fröhner B and Suárez Fernández R: Episcleral infantile hemangioma
successfully treated with topical timolol. Dermatol Ther. 28:22–24.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coppens G, Stalmans I, Zeyen T and
Casteels I: The safety and efficacy of glaucoma medication in the
pediatric population. J Pediatr Ophthalmol Strabismus. 46:12–18.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lohmöller G and Frohilch ED: A comparison
of timolol and propranolol in essential hypertension. Am Heart J.
89:437–442. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Achong MR, Piafsky KM and Ogilvie RI:
Duration of cardiac effects of timolol and propranolol. Clin
Pharmacol Ther. 19:148–152. 1976.PubMed/NCBI
|
|
19
|
Ni N, Langer P, Wagner R and Guo S:
Topical timolol for periocular hemangioma: Report of further study.
Arch Ophthalmol. 129:377–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Mai HM and Zheng JW: The
mechanisms of propranolol treatment for infantile hemangiomas and
advances in research. Zhong Guo Kou Qiang Zuo Mian Wai Ke Za Zhi
She. 10:342–346. 2012.(In Chinese).
|
|
21
|
Ding SM, Qu W, Wang SJ, Feng J, Zheng XH
and Song C: Clinical observation of hemangioma treated by 90Sr/90Y
application. Zhong Guo Pi Fu Xing Bing Xue Za Zhi She. 11:673–674.
2006.(In Chinese).
|
|
22
|
McMahon P, Oza V and Frieden IJ: Topical
timolol for infantile hemangiomas: Putting a note of caution in
‘cautiously optimistic’. Pediatr Dermatol. 29:127–130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
